Psoriasis, Ultraviolet Light, and Chloroquine

O'Quinn, Silas E.

doi:10.1001/archderm.1964.01600020079020

Search citation statements

Order By: Relevance

Paper Sections

Select...

Patient 9: Worsening Of Pre-existing Psoriasis1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1966

2010

Publication Types

Select...

Article4

Other2

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 18 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chloroquine has been associated with flares of psoriasis. 4,5 In this patient it is possible but unlikely that the antimalarial was responsible for the psoriatic flare-up. The temporal association between starting the drug and flare-up of psoriasis favours terbinafine.…”

Section: Patient 9: Worsening Of Pre-existing Psoriasismentioning

confidence: 85%

Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature

Gupta

Lynde

Lauzon

et al. 1998

British Journal of Dermatology

View full text Add to dashboard Cite

Terbinafine is an allylamine antifungal agent widely used to treat dermatophyte onychomycosis and dermatomycoses. We report 10 severe cutaneous adverse reactions associated with terbinafine therapy which required discontinuation of the antifungal agent: erythema multiforme (five patients), erythroderma (one), severe urticaria (one), pityriasis rosea (one) and worsening of pre-existing psoriasis (two patients). The spectrum of cutaneous adverse effects associated with terbinafine therapy is reviewed. Patients should be counselled about discontinuing terbinafine at the onset of a cutaneous eruption and about seeking medical advice about further management.

show abstract

Section: Patient 9: Worsening Of Pre-existing Psoriasismentioning

confidence: 85%